Poor Biosimilarity Practices, Impurities and New Technologies Debated At European Pharmacopoeia Event

 
• By Ian Schofield
  
Quality Management
Quality of medicines - the central task of the European Pharmacopoeia

More from Manufacturing

More from Compliance